1. Home
  2. NMT vs RFL Comparison

NMT vs RFL Comparison

Compare NMT & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Massachusetts Quality Municipal Income Fund

NMT

Nuveen Massachusetts Quality Municipal Income Fund

N/A

Current Price

$10.49

Market Cap

114.0M

Sector

Finance

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.50

Market Cap

133.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NMT
RFL
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
133.1M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
NMT
RFL
Price
$10.49
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
44.9K
★ 110.1K
Earning Date
01-01-0001
10-28-2026
Dividend Yield
★ 3.21%
N/A
EPS Growth
N/A
★ 28.28
EPS
★ N/A
N/A
Revenue
N/A
★ $917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 43.96
52 Week Low
$10.02
$1.12
52 Week High
$13.70
$3.96

Technical Indicators

Market Signals
Indicator
NMT
RFL
Relative Strength Index (RSI) 25.97 22.43
Support Level N/A $1.22
Resistance Level $12.89 $1.37
Average True Range (ATR) 0.27 0.16
MACD -0.06 -0.09
Stochastic Oscillator 31.79 3.70

Price Performance

Historical Comparison
NMT
RFL

About NMT Nuveen Massachusetts Quality Municipal Income Fund

Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The company has single operating segment.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: